Jubiglim Trio 1 Tablet PR
By Jubiglim Trio
Rx
10 Tablet PR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Jubilant Life Sciences
1A, Sector 16A, Noida - 201 301, Uttar Pradesh, India

Expires on or after
June, 2026

liver
When using Jubiglim Trio 1 Tablet PR, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of this medication, so it is advisable to consult your doctor before starting treatment. Patients with severe liver disease are not recommended to use Jubiglim Trio 1 Tablet PR.

kidney
Jubiglim Trio 1 Tablet PR should be used with caution in patients with kidney disease. Dose adjustment may be needed, and it is not recommended in severe kidney disease. Regular monitoring of kidney function is advisable while taking this medicine. Please consult your doctor.

alcohol
It is not safe to drink alcohol while taking Jubiglim Trio 1 Tablet PR. Avoid alcohol consumption with this medication. Consult your doctor when cosuming alcohol with Jubiglim Trio 1 Tablet PR.

driving
When taking Jubiglim Trio 1 Tablet PR, it is important to note that your driving ability could be influenced if your blood sugar levels are too low or too high. Avoid driving if you experience these symptoms.

pregnancy
Jubiglim Trio 1 Tablet PR is considered unsafe during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits versus risks before using this medication during pregnancy.

breastfeeding
Jubiglim Trio 1 Tablet PR is likely unsafe while breastfeeding. Limited data suggests it may pass into breastmilk, posing harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹72
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024